Profound Medical Corp (PRN.TO)
10.01
-0.07
(-0.69%)
CAD |
TSX |
May 31, 16:00
Profound Medical Total Assets (Quarterly): 77.69M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 77.69M |
| December 31, 2023 | 58.23M |
| September 30, 2023 | 68.54M |
| June 30, 2023 | 75.27M |
| March 31, 2023 | 82.81M |
| December 31, 2022 | 87.39M |
| September 30, 2022 | 87.63M |
| June 30, 2022 | 94.08M |
| March 31, 2022 | 100.20M |
| December 31, 2021 | 110.59M |
| September 30, 2021 | 119.33M |
| June 30, 2021 | 118.81M |
| March 31, 2021 | 125.92M |
| December 31, 2020 | 133.37M |
| September 30, 2020 | 131.78M |
| June 30, 2020 | 76.79M |
| March 31, 2020 | 82.65M |
| December 31, 2019 | 39.26M |
| September 30, 2019 | 42.91M |
| Date | Value |
|---|---|
| June 30, 2019 | 37.77M |
| March 31, 2019 | 44.86M |
| December 31, 2018 | 46.56M |
| September 30, 2018 | 49.58M |
| June 30, 2018 | 46.43M |
| March 31, 2018 | 51.84M |
| December 31, 2017 | 27.87M |
| September 30, 2017 | 31.49M |
| June 30, 2017 | 15.93M |
| March 31, 2017 | 20.76M |
| December 31, 2016 | 23.76M |
| September 30, 2016 | 12.06M |
| June 30, 2016 | 14.78M |
| March 31, 2016 | 18.05M |
| December 31, 2015 | 21.18M |
| September 30, 2015 | 24.22M |
| June 30, 2015 | 27.01M |
| March 31, 2015 | 1.661M |
| September 30, 2014 | 1.815M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
37.77M
Minimum
Jun 2019
133.37M
Maximum
Dec 2020
87.55M
Average
85.10M
Median
Total Assets (Quarterly) Benchmarks
| Biocure Technology Inc | 1.979M |
| Core One Labs Inc | 7.400M |
| Nova Mentis Life Science Corp | 0.0539M |
| Nanosphere Health Sciences Inc | 0.0238M |
| Lobe Sciences Ltd | 2.109M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 15.60M |
| Shareholders Equity (Quarterly) | 62.09M |
| Debt to Equity Ratio | 0.1413 |
| Current Ratio | 5.410 |
| Net Debt Paydown Yield | 0.07% |